what is a glp 1 agonist medication GLP-1 receptor agonists Researchers find GLP-1 medications safe

The GLP-1 receptor agonist market size was exhibited at USD 36.95 billion in 2023 and is projected to hit around USD 261.19 billion by 2033, growing at a CAGR of 21.6% during the forecast period 2024 to 2033.

Even more concerning

Diabetes mellitus, a condition that significantly elevates the incidence and mortality risks associated with cardiovascular diseases, exacerbates the disease burden in China

This product does not contain synthetic GLP-1 and is not a GLP-1 agonist drug

Natural GLP1 plays a crucial role in regulating appetite, blood sugar, and overall metabolic health, yet many seek ways to enhance its levels without relying on medication

New data is illuminating the full profile of GLP-1 side effects